B. Riley lowered the firm’s price target on Varex Imaging (VREX) to $12 from $22 and keeps a Buy rating on the shares. Varex Imaging’s Q2 results were at the upper end of revenue guidance and above earnings guidance, the analyst tells investors in a research note. The firm notes that the 125% retaliatory tariffs have put the recovery in China on hold as Chinese customers have paused deliveries in anticipation of potential improvements in trade relations with the U.S. or potential exemptions for Varex products, which is expected to result in the loss of 2/3 of revenue from China in Q3 vs. Q2.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VREX:
